Start date: 01 May 2023
End date: 30 April 2028
The Obelisk project consists of developing tools for predicting obesity during the first 1,000 days of life and testing innovative prevention programs, particularly among adolescents, in several countries.
Another dimension of the project concerns the understanding of the genetic determinants of obesity, 5 to 10% of situations being explained by an anomaly in the gene that controls appetite. But social and cultural factors will also be studied. Finally, scientists in Lille will conduct a therapeutic trial to measure the effect on obesity of a drug used to treat diabetes.
The goal is to disseminate protocols for the prevention and optimal treatment of childhood obesity at the European level in order to reduce by 35% the number of overweight children who become obese as adults.
Scientific coordinator of the project: Philippe Froguel